Financhill
Back

Masimo Quote, Financials, Valuation and Earnings

Masimo Price Quote

$169.52
-0.03 (-0.28%)
(Updated: December 21, 2024 at 5:35 AM ET)

Masimo Key Stats

Sell
48
Masimo (MASI) is a Sell

Day range:
$166.97 - $173.26
52-week range:
$101.61 - $180.97
Dividend yield:
0%
P/E ratio:
112.28
P/S ratio:
4.51
P/B ratio:
6.2%

Volume:
975.5K
Avg. volume:
526.2K
1-year change:
49.07%
Market cap:
$9.1B
Revenue:
$2B
EPS:
$1.45

How Much Does Masimo Make?

Data Unavailable

Is Masimo Growing As A Company?

Data Unavailable

Masimo Stock Price Performance

  • Did Masimo Stock Go Up Last Month?
    Masimo share price went up by 2.79% last month
  • Did MASI's Share Price Rise Over The Last Year?
    MASI share price rose by 49.07% over the past 1 year

What Is Masimo 52-Week High & Low?

  • What Is Masimo’s 52-Week High Share Price?
    Masimo has traded as high as $180.97 over the past 52 weeks
  • What Is Masimo’s 52-Week Low Share Price?
    Masimo has traded as low as $101.61 over the past 52 weeks

Masimo Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Masimo?

Data Unavailable

Is Masimo Cash Flow Positive?

Data Unavailable

Masimo Return On Invested Capital

Data Unavailable

Masimo Earnings Date & Stock Price

  • What Is Masimo's Stock Price Today?
    A single share of MASI can be purchased today for 169.55
  • What Is Masimo’s Stock Symbol?
    Masimo trades on the nasdaq under the ticker symbol: MASI
  • When Is Masimo’s Next Earnings Date?
    The next quarterly earnings date for Masimo is scheduled on February 27, 2025
  • When Is MASI's next ex-dividend date?
    Masimo's next ex-dividend date is May 12, 2020
  • How To Buy Masimo Stock?
    You can buy Masimo shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Masimo Competitors

  • Who Are Masimo's Competitors?
    Below is a list of companies who compete with Masimo or are related in some way:
    • Abbott Laboratories (ABT)
    • AngioDynamics Inc (ANGO)
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Tandem Diabetes Care Inc (TNDM)

Masimo Dividend Yield

Data Unavailable

Masimo Analyst Estimates

YoY Growth Past Surprise
EPS: -10% 17.13%
Revenue: 5.37% 0.35%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 172.77
Upside from Last Price: 1.9%

Major Shareholders

Data Unavailable